StudyTeam
Care AccessPaper workflows
Easy-to-use and secure, eSource is the recommended method for capturing source data in one, central place.
With StudyTeam eSource, we create electronic source forms for your site to effectively capture and manage source data per protocol, right within StudyTeam.
With source forms customized for your study, you can reduce the challenges of paper-only source documentation, including:
Take your productivity to the next level and free up time for patient care.
Improve data accuracy with the legibility of digital data entry along with built-in validation and checks.
Activate secure storage when you organize source data into electronic patient binders.
If you prefer paper, print templates with QR codes, then upload and automatically categorize completed forms.
Remotely grant access to other stakeholders for PI review and authentication, auditing, monitoring and Source Data Verification.
It's currently available for all sites based in the United States.
Yes. StudyTeam eSource is compliant with data protection laws. The Data Protection team at OneStudyTeam actively tracks and monitors the ever-changing regulatory landscape to remain compliant as new regulations are introduced. OneStudyTeam recognizes that field can change quickly and we take an active stance toward compliance.Learn more about our data security and privacy here.
Yes, OneStudyTeam employs industry best practices to keep your data secure and accessible. Detailed standard operating procedures have been developed to ensure StudyTeam eSource is validated and in compliance with applicable regulations such as the FDA’s 21 CFR Part 11.
Yes. While we build the templates for you, you are welcome to customize the source templates so they fit best with your workflow.
Yes. For the most streamlined workflows, the electronic eSource binders are built right into StudyTeam, where you may already be managing patient pre-screening and enrollment. Sites can get the StudyTeam patient enrollment management platform for free.
Get OneStudyTeam news and clinical trial enrollment insights delivered directly to your inbox.
